Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 12 studies | 25% ± 8% | |
lung | 8 studies | 25% ± 7% | |
kidney | 6 studies | 19% ± 2% | |
intestine | 6 studies | 22% ± 11% | |
bone marrow | 4 studies | 21% ± 3% | |
uterus | 4 studies | 26% ± 12% | |
liver | 4 studies | 34% ± 26% | |
lymph node | 4 studies | 20% ± 5% | |
brain | 4 studies | 22% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 3063.25 | 258 / 258 | 100% | 26.52 | 230 / 230 |
ovary | 100% | 3407.35 | 180 / 180 | 100% | 23.73 | 430 / 430 |
brain | 100% | 2284.03 | 2637 / 2642 | 100% | 31.67 | 705 / 705 |
prostate | 100% | 3976.12 | 245 / 245 | 100% | 28.03 | 501 / 502 |
uterus | 100% | 3921.92 | 170 / 170 | 100% | 23.53 | 458 / 459 |
stomach | 100% | 2301.85 | 359 / 359 | 100% | 15.85 | 285 / 286 |
intestine | 100% | 3102.70 | 966 / 966 | 100% | 17.23 | 525 / 527 |
thymus | 100% | 2651.74 | 653 / 653 | 100% | 21.73 | 602 / 605 |
esophagus | 100% | 2777.29 | 1445 / 1445 | 99% | 11.48 | 182 / 183 |
bladder | 100% | 3341.76 | 21 / 21 | 99% | 20.42 | 500 / 504 |
skin | 100% | 1560.42 | 1806 / 1809 | 99% | 21.58 | 469 / 472 |
liver | 100% | 1141.85 | 225 / 226 | 100% | 14.58 | 404 / 406 |
lung | 100% | 2003.46 | 576 / 578 | 99% | 14.97 | 1148 / 1155 |
pancreas | 99% | 1183.78 | 326 / 328 | 99% | 18.77 | 177 / 178 |
breast | 100% | 2423.70 | 459 / 459 | 99% | 16.82 | 1102 / 1118 |
kidney | 100% | 2465.03 | 89 / 89 | 99% | 16.96 | 888 / 901 |
adipose | 100% | 2298.54 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 23.31 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 56.91 | 29 / 29 |
spleen | 100% | 3529.54 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 17.75 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 19.45 | 1 / 1 |
blood vessel | 100% | 3271.80 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 100% | 1923.70 | 858 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 1634.28 | 905 / 929 | 0% | 0 | 0 / 0 |
muscle | 95% | 959.63 | 764 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006298 | Biological process | mismatch repair |
GO_0006401 | Biological process | RNA catabolic process |
GO_0032299 | Cellular component | ribonuclease H2 complex |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
Gene name | RNASEH2C |
Protein name | Ribonuclease H2 subunit C Ribonuclease H2 subunit C (RNase H2 subunit C) (Aicardi-Goutieres syndrome 3 protein) (AGS3) (RNase H1 small subunit) (Ribonuclease HI subunit C) |
Synonyms | AYP1 |
Description | FUNCTION: Non catalytic subunit of RNase H2, an endonuclease that specifically degrades the RNA of RNA:DNA hybrids. Participates in DNA replication, possibly by mediating the removal of lagging-strand Okazaki fragment RNA primers during DNA replication. Mediates the excision of single ribonucleotides from DNA:RNA duplexes. . |
Accessions | ENST00000527610.1 ENST00000534482.6 ENST00000308418.10 Q8TDP1 E9PN81 ENST00000531596.6 ENST00000644142.1 |